Read More

MorphoSys Spokesperson Says “This Story Is Factually Wrong” In An Emailed Statement To Bloomberg News, In Response To STAT News’ Adam Feuerstein Article Entitled, “Why Novartis Is Going To Walk Away From Its Acquisition”

Why Novartis is going to walk from its acquisition of MorphoSys (statnews.com) Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or

MOR